PD
RAPT

Point72 (DIFC)’s RAPT Therapeutics RAPT Stock Holding History

Point72 (DIFC)’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$405 Buy
+16
New +$209 ﹤0.01% 1094
2024
Q3 		– Sell
-1,087
Closed -$26.5K – 1752
2024
Q2 		$26.5K Sell
1,087
-5,354
-83% -$247K ﹤0.01% 1191
2024
Q1 		$463K Buy
+6,441
New +$896K 0.01% 770

Other funds holding RAPT

MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCM
Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Point72 (DIFC)'s RAPT Position: Q3 2025 in Review

Point72 (DIFC) opened a new position in RAPT Therapeutics (RAPT) in Q3 2025: 16 shares worth $405. The stake represents ﹤0.01% of the portfolio and ranks #1094 among its holdings. This is a return to the name: Point72 (DIFC) previously reported a position in RAPT as recently as Q2 2024.

Point72 (DIFC) first reported a position in RAPT in Q1 2024 and has held it in 3 quarters since. The position peaked at $463K in Q1 2024. 65 funds tracked by Wall St. Rank hold RAPT as of Q3 2025.

  • Point72 (DIFC) held 16 shares of RAPT Therapeutics worth $405 as of Q3 2025.
  • RAPT Therapeutics was a new Point72 (DIFC) position in Q3 2025.
  • RAPT Therapeutics made up ﹤0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #1094 holding.
  • Point72 (DIFC) first reported a position in RAPT Therapeutics in Q1 2024 and has held it in 3 quarters since.
  • Point72 (DIFC)'s RAPT Therapeutics position peaked at $463K in Q1 2024.
  • 65 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.